DK513578A - Fremgangsmaade til fremstilling af triazolylbenzopenoner - Google Patents

Fremgangsmaade til fremstilling af triazolylbenzopenoner

Info

Publication number
DK513578A
DK513578A DK513578A DK513578A DK513578A DK 513578 A DK513578 A DK 513578A DK 513578 A DK513578 A DK 513578A DK 513578 A DK513578 A DK 513578A DK 513578 A DK513578 A DK 513578A
Authority
DK
Denmark
Prior art keywords
triazolylbenzopenones
procedure
preparation
Prior art date
Application number
DK513578A
Other languages
English (en)
Inventor
J B Hester
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US00372313A external-priority patent/US3856792A/en
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of DK513578A publication Critical patent/DK513578A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DK513578A 1971-02-09 1978-11-17 Fremgangsmaade til fremstilling af triazolylbenzopenoner DK513578A (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11404971A 1971-02-09 1971-02-09
US24075672A 1972-04-03 1972-04-03
US00372313A US3856792A (en) 1971-02-09 1973-06-21 2-{8 2-(substituted aminomethyl)-4h-1,2,4-triazol-4-yl{9 benzophenones

Publications (1)

Publication Number Publication Date
DK513578A true DK513578A (da) 1978-11-17

Family

ID=27381433

Family Applications (1)

Application Number Title Priority Date Filing Date
DK513578A DK513578A (da) 1971-02-09 1978-11-17 Fremgangsmaade til fremstilling af triazolylbenzopenoner

Country Status (14)

Country Link
US (1) US3709898A (da)
JP (1) JPS4966679A (da)
BE (1) BE779144A (da)
BR (1) BR7200590D0 (da)
CA (1) CA966123A (da)
CH (2) CH569736A5 (da)
DE (2) DE2265617C3 (da)
DK (1) DK513578A (da)
FR (1) FR2124559B1 (da)
GB (4) GB1374824A (da)
HK (1) HK2580A (da)
NL (1) NL151709B (da)
SE (1) SE414928B (da)
ZA (1) ZA7251B (da)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE397831B (sv) * 1971-06-05 1977-11-21 Takeda Chemical Industries Ltd Sett att framstella s-triazolo-(4,3-a)(1,4)bensodiazepinderivat
US3904641A (en) * 1971-06-18 1975-09-09 Yoshitomi Pharmaceutical Triazolothienodiazepine compounds
BE790838A (fr) * 1971-11-02 1973-04-30 Upjohn Co Nouvelles 1-aminophenyl-6-phenyl-s-triazolo (4,3-a) (1,4)- benzodiazepines, leur procede de preparation et medicament les contenant
CH586704A5 (da) * 1973-02-14 1977-04-15 Upjohn Co
US3879413A (en) * 1973-02-14 1975-04-22 Upjohn Co Process for the production of 6-phenyl-4-H-s-triazolo {8 4,3-a{9 {8 1,4{9 benzodiazepines
US3842090A (en) * 1973-02-14 1974-10-15 Upjohn Co Certain 1-aminomethyl-6-phenyl 4h-s-triazolo(4,3-a)(1,4)benzodiazepines
US4263310A (en) * 1974-03-02 1981-04-21 Boehringer Ingelheim Gmbh 8-Bromo-6-(o-chloro-phenyl)-4H-S-triazolo-[3,4,-c]-thieno-[2,3-e]-1,4-diazepines and salts thereof
GB1517164A (en) * 1974-08-20 1978-07-12 Roche Products Ltd Substituted-phenyl ketones and a process for the manufacture thereof
US4000151A (en) * 1974-09-11 1976-12-28 The Upjohn Company Triazolyl benzophenone compounds
US4000153A (en) * 1974-09-26 1976-12-28 The Upjohn Company Triazolobenzodiazepine intermediates
FR2290213A1 (fr) * 1974-11-06 1976-06-04 Parke Davis & Co Nouveaux derives de diazepine et procedes pour leur production
CH601267A5 (da) * 1975-12-12 1978-06-30 Ciba Geigy Ag
US4075408A (en) * 1975-09-08 1978-02-21 Parke, Davis & Company Imidazopyrazolodiazepine compounds
US4009175A (en) * 1976-03-15 1977-02-22 The Upjohn Company 1-[(Aminooxy)-methyl]-6-substituted-4H-s-triazolo[4,3-a][1,4] benzodiazepines
US4409390A (en) * 1981-07-23 1983-10-11 Hoffmann-La Roche Inc. Pyrrolo[3,4-D][2]Benzazepines
US4405518A (en) * 1981-07-23 1983-09-20 Hoffmann-La Roche Inc. Pyrrolo[3,4-d] [2] benzazepines
US4375473A (en) * 1982-01-04 1983-03-01 The Upjohn Company Method
US4501698A (en) * 1983-03-31 1985-02-26 The Upjohn Company Preparing 1-(hydroxymethyl)-triazolobenzodiazepines and 1-(aminomethyl)-triazolobenzodiazepines
EP2902030B1 (en) 2010-05-14 2016-09-14 Dana-Farber Cancer Institute, Inc. Thienotriazolodiazepine compounds for treating neoplasia
AU2015201727B2 (en) * 2010-05-14 2018-03-08 Dana-Farber Cancer Institute, Inc. Compositions and methods for treating neoplasia, inflammatory disease and other disorders
BR112012029057A2 (pt) 2010-05-14 2020-10-13 Dana-Farber Cancer Institute, Inc. composições e métodos de tratamento de leucemia
CA2799381A1 (en) 2010-05-14 2011-11-17 Dana-Farber Cancer Institute, Inc. Male contraceptive compositions and methods of use
AR084070A1 (es) 2010-12-02 2013-04-17 Constellation Pharmaceuticals Inc Inhibidores del bromodominio y usos de los mismos
US9249161B2 (en) 2010-12-02 2016-02-02 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
US9422292B2 (en) 2011-05-04 2016-08-23 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
WO2012174487A2 (en) 2011-06-17 2012-12-20 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
TWI602820B (zh) 2012-06-06 2017-10-21 星宿藥物公司 溴域抑制劑及其用途
EP2864336B1 (en) 2012-06-06 2016-11-23 Constellation Pharmaceuticals, Inc. Benzo[b]isoxazoloazepine bromodomain inhibitors and uses thereof
BR112016001457A2 (pt) 2013-07-25 2017-08-29 Dana Farber Cancer Inst Inc Inibidores de fatores de transcrição e usos dos mesmos
US11446309B2 (en) 2013-11-08 2022-09-20 Dana-Farber Cancer Institute, Inc. Combination therapy for cancer using bromodomain and extra-terminal (BET) protein inhibitors
JP2017504651A (ja) 2014-01-31 2017-02-09 ダナ−ファーバー キャンサー インスティテュート, インコーポレイテッド ジアゼパン誘導体の使用
RU2016134947A (ru) 2014-01-31 2018-03-01 Дана-Фарбер Кансер Институт, Инк. Производные диаминопиримидин бензолсульфона и их применение
WO2015131113A1 (en) 2014-02-28 2015-09-03 Tensha Therapeutics, Inc. Treatment of conditions associated with hyperinsulinaemia
EP3157928B1 (en) 2014-06-20 2019-02-13 Constellation Pharmaceuticals, Inc. Crystalline forms of 2-((4s)-6-(4-chlorophenyl)-1-methyl-4h-benzo[c]isoxazolo[4,5-e]azepin-4-yl)acetamide
JP2017526741A (ja) 2014-08-08 2017-09-14 ダナ−ファーバー キャンサー インスティテュート, インコーポレイテッド ジアゼパン誘導体およびその使用
JP2017525759A (ja) 2014-08-08 2017-09-07 ダナ−ファーバー キャンサー インスティテュート, インコーポレイテッド ジヒドロプテリジノン誘導体およびその使用
WO2016069578A1 (en) 2014-10-27 2016-05-06 Tensha Therapeutics, Inc. Bromodomain inhibitors
WO2016201370A1 (en) 2015-06-12 2016-12-15 Dana-Farber Cancer Institute, Inc. Combination therapy of transcription inhibitors and kinase inhibitors
BR112018004617A2 (pt) 2015-09-11 2018-09-25 Dana Farber Cancer Inst Inc acetamida tienotriazoldiazepinas e usos das mesmas
RU2750164C2 (ru) 2015-09-11 2021-06-22 Дана-Фарбер Кэнсер Инститьют, Инк. Цианотиенотриазолодиазепины и пути их применения
CR20180336A (es) 2015-11-25 2018-08-06 Dana Farber Cancer Inst Inc Inhibidores de bromodominio bivalentes y usos de los mismos

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3413346A (en) * 1966-01-19 1968-11-26 Hoffmann La Roche 2-(2-haloethylamino)-5-halo-benzophenones
US3987052A (en) * 1969-03-17 1976-10-19 The Upjohn Company 6-Phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepines
DE1955349C2 (de) * 1969-11-04 1982-01-28 Takeda Chemical Industries, Ltd., Osaka s-Triazolo [4,3-a] [1,4] benzodiazepine
YU34997B (en) * 1970-03-27 1980-06-30 Hiroyuki Tawada Process for preparing benzodiazepine derivatives

Also Published As

Publication number Publication date
US3709898A (en) 1973-01-09
CA966123A (en) 1975-04-15
DE2203782C2 (de) 1982-05-13
ZA7251B (en) 1972-09-27
DE2265617C3 (de) 1982-05-06
DE2203782A1 (de) 1972-08-24
GB1374822A (en) 1974-11-20
GB1374824A (en) 1974-11-20
GB1374823A (en) 1974-11-20
BE779144A (fr) 1972-08-09
CH570404A5 (da) 1975-12-15
CH569736A5 (da) 1975-11-28
NL151709B (nl) 1976-12-15
NL7201692A (da) 1972-08-11
BR7200590D0 (pt) 1973-07-17
FR2124559A1 (da) 1972-09-22
HK2580A (en) 1980-01-25
SE414928B (sv) 1980-08-25
DE2265617B2 (de) 1981-07-16
JPS4966679A (da) 1974-06-27
FR2124559B1 (da) 1975-08-01
AU3772572A (en) 1973-07-12
GB1374825A (en) 1974-11-20

Similar Documents

Publication Publication Date Title
DK513578A (da) Fremgangsmaade til fremstilling af triazolylbenzopenoner
DK138419B (da) Fremgangsmåde til fremstilling af 1alfa-hydroxycholecalciferol.
DK132400C (da) Fremgangsmade til fremstilling af aromatiske hydroxyaldehyder
DK139966C (da) Fremgangsmaade til fremstilling af 1-hydroxy-2-pyridoner
DK136062C (da) Fremgangsmade til fremstilling af 2-alkylamino-dihydropyridiner
DK132711C (da) Fremgangsmade til fremstilling af cephalosporin c
DK133470B (da) Fremgangsmåde til fremstilling af 3alfa-hydroxy-5alfa-steroider.
DK132795C (da) Fremgangsmade til fremstilling af 2,4-diamino-5-benzylpyrimidiner
DK134782C (da) Fremgangsmade til fremstilling af 3beta-hydroxy-5beta-h-steroider
DK132221C (da) Fremgangsmade til fremstilling af 2,4-diamino-5-benzylpyrimidiner
DK132586C (da) Fremgangsmade til fremstilling af erythromycylaminer
DK136034C (da) Analogifremgangsmade til fremstilling af sulfamoylpyrimidiner
DK139270C (da) Fremgangsmaade til fremstilling af alfa-kobberphthalocyanin
DK126780B (da) Fremgangsmåde til fremstilling af flavon-7-oxyacetater.
DK132703C (da) Fremgangsmade til fremstilling af 2,4-diamino-5-benzylpyrimidiner
DK131786C (da) Fremgangsmade til fremstilling af delta4-3-oxo-1alfa-methylsteroider
DK140551B (da) Fremgangsmaade til fremstilling af diazabicycloalkanderivater
DK133277C (da) Fremgangsmade til fremstilling af trans-chrysanthemsyre
DK132223C (da) Analogifremgangsmade til fremstilling af benzensulfonamidopyrimidiner
DK143562C (da) Fremgangsmaade til fremstilling af (-)-vincamin
DK139577C (da) Fremgangsmaade til fremstilling af des-phenylalaninb1-insulin
DK133777C (da) Fremgangsmade til fremstilling af alfa-oximinonitriler
DK132663C (da) Fremgangsmade til fremstilling af transparente polyamider
DK125788B (da) Fremgangsmåde til fremstilling af p-nitrophenoler.
DK245279A (da) Fremgangsmaade til fremstilling af oxoazetidinderivater

Legal Events

Date Code Title Description
ATS Application withdrawn